About the 17th Annual Biotech in Europe Forum
The forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. We expect over 650 delegates and over 100 presenting companies.
The 17th Annual BEF will be held for the fourth time in Basel to be close to the largest biopharma hub in Europe and the Congress Center provides meeting space capable of handling several thousand one-to-one meetings as well as significant exhibition space. The Programme will feature twelve plenary panels/workshops covering BD & Licensing in the main therapeutic areas.The Forum will provide a number of networking opportunities via our online one-to-one meeting system which allows you to pre-book meetings with all the attendees with dedicated meeting facilities. We expect more than 1500 meetings to take place throughout the 2 days.